Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells

Area of Science:

• Genomics
• Molecular Biology
• Bioinformatics

Background:

• Down syndrome (DS) results from trisomy of chromosome 21 (Hsa21).
• Understanding gene expression in DS is crucial for developing targeted therapies for intellectual disability.
• Existing gene expression datasets for DS are fragmented across various cell types and platforms.

Purpose of the Study:

• To generate integrated, quantitative transcriptome maps for Down syndrome.
• To model gene expression and segmental trends along chromosomes in DS.
• To identify genes and chromosomal regions critical to DS pathogenesis.

Main Methods:

• Utilized TRAM (Transcriptome Mapper) software for meta-analysis of diverse gene expression datasets.
• Normalized and integrated data from multiple sources and experimental platforms.
• Validated in silico findings with in vitro Real-Time RT-PCR, achieving high correlation (r=0.93).

Main Results:

• Developed a reference transcriptome map with linear expression values for up to 37,181 transcripts.
• Confirmed selective over-expression of Hsa21 genes in DS compared to other chromosomes.
• Identified specific over-expressed segments on Hsa21, notably 21q22, implicating them in DS pathogenesis.
• Demonstrated that most, but not all, Hsa21 genes are subject to gene dosage effects.

Conclusions:

• The generated transcriptome maps provide a comprehensive framework for DS research.
• Over-expression of Hsa21 genes, particularly in the 21q22 region, plays a significant role in Down syndrome.
• These findings offer insights for developing rational therapeutic strategies for DS-associated conditions.